Context Therapeutics's market cap is currently $59.25M. The company's EPS TTM is $-0.911; its P/E ratio is ―; Context Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -12.04K	$ -9.27K	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -25.07M	$ -15.38M	$ -10.53M	$ -2.57M	$ -5.38M
EBITDA	$ -25.06M	$ -14.83M	$ -10.53M	$ 0.00	$ 0.00
Net Income	$ -23.96M	$ -14.29M	$ -7.43M	$ 6.64M	$ -7.48M
Balance Sheet
Cash & Short-Term Investments	$ 14.45M	$ 35.50M	$ 49.64M	$ 341.04K	$ 226.60K
Total Assets	$ 16.06M	$ 37.97M	$ 51.31M	$ 467.34K	$ 273.55K
Total Debt	$ 0.00	$ 55.08K	$ 0.00	$ 5.95M	$ 21.84M
Net Debt	$ -14.45M	$ -35.44M	$ -49.64M	$ 5.61M	$ 21.62M
Total Liabilities	$ 4.19M	$ 3.21M	$ 3.03M	$ 17.39M	$ 24.23M
Stockholders' Equity	$ 11.87M	$ 34.76M	$ 48.27M	$ -16.92M	$ -23.96M
Cash Flow
Free Cash Flow	$ -21.05M	$ -14.09M	$ -9.05M	$ -1.03M	$ -2.84M
Operating Cash Flow	$ -21.05M	$ -13.55M	$ -8.80M	$ -1.03M	$ -2.84M
Investing Cash Flow	$ 0.00	$ -536.84K	$ -250.00K	$ 0.00	$ 0.00
Financing Cash Flow	$ 0.00	$ -102.07K	$ 58.39M	$ 1.15M	$ 1.96M

Currency in USD

Context Therapeutics Earnings and Revenue History

Income Statement >

Context Therapeutics Debt to Assets

Balance Sheet >

Context Therapeutics Cash Flow

Cash Flow >

Context Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing